Jeevan Scientific Technology Limited

BSE: JSTL538837ISIN INE237B01018

Healthcare
Healthcare Research, Analytics & Technology

Share price

₹81.70-1.31 (-1.58%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹93.90
52W low: ₹57.15
Off 52W high: -12.99%
1M return: -2.17%
3M return: +1.35%
6M return: -8.64%
1Y return: +30.72%
20D avg volume: 40,179
50 DMA: ₹80.62
200 DMA: ₹75.32

Key ratios Consolidated

Market cap: ₹164.06 Cr
Current price: ₹81.70
52W high / low: ₹93.90 / ₹57.15
Face value: ₹10.00
P/E: 32.02
P/B: 2.26
EPS (TTM): ₹2.55
Book value / share: ₹36.12
ROE: —
ROCE: 4.80%
Operating margin: —
Net margin: —
Debt / equity: 0.24
Net debt: ₹7.65 Cr
Interest cover: 2.02
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 104.3 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	18.28	21.29	19.07	12.38	8.80	10.06	12.51	11.40	12.88	—
	0.17	0.29	0.14	0.20	0.33	0.15	0.23	0.16	0.12	—
	18.45	21.58	19.21	12.58	9.13	10.21	12.73	11.56	12.99	—
	17.47	19.00	15.99	12.55	12.86	12.76	12.34	10.84	11.50	—
	1.71	1.62	1.49	1.00	0.77	1.15	0.85	0.81	0.99	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	5.74	5.97	5.55	5.10	5.02	4.99	4.03	4.05	3.99	—
	0.44	0.41	0.54	0.55	0.54	0.55	0.43	0.45	0.33	—
	1.70	1.61	1.60	1.69	1.74	1.77	1.48	1.49	1.51	—
	7.87	9.39	6.81	4.21	4.79	4.30	5.55	4.05	4.68	—
	0.98	2.58	3.23	0.03	-3.73	-2.55	0.39	0.72	1.49	—
	0.00	-0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.98	2.56	3.23	0.03	-3.73	-2.55	0.39	0.72	1.49	—
	0.11	0.72	0.83	0.02	-0.51	1.29	0.35	0.47	0.47	—
	0.87	1.84	2.40	0.01	-3.22	-1.26	0.05	0.25	1.03	—
	0.44	0.92	1.52	0.01	-2.03	-0.81	0.03	0.16	0.66	—
Key metrics
	3.12	4.58	5.37	2.27	-1.45	-0.23	2.30	2.66	3.33	—
	17.10%	21.50%	28.20%	18.30%	-16.50%	-2.30%	18.40%	23.30%	25.90%	—
	4.80%	8.60%	12.60%	0.10%	-36.60%	-12.50%	0.40%	2.20%	8.00%	—
	—	3.40%	—	1.00%	—	-3.00%	—	—	—	—
	107.70%	111.60%	52.40%	8.60%	-31.70%	—	—	—	—	—
	127.00%	246.00%	4,700.00%	-96.00%	-412.60%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	71.02	61.54	46.84	—
	0.80	0.97	0.65	—
	71.82	62.51	47.50	—
	65.01	60.40	47.45	—
	5.82	4.88	3.80	—
	0.00	0.00	0.00	—
	22.36	21.64	17.06	—
	1.94	2.04	1.76	—
	6.60	6.64	6.25	—
	28.28	25.20	18.57	—
	6.82	2.11	0.05	—
	-0.02	-0.02	0.00	—
	6.80	2.09	0.05	—
	1.68	1.06	-0.01	—
	5.12	1.03	0.06	—
	2.89	0.52	0.04	—
Key metrics
	15.34	10.77	8.06	—
	21.60%	17.50%	17.20%	—
	7.21%	1.70%	0.10%	—
	—	4.80%	2.70%	—
	66.05%	31.40%	—	—
	—	1,616.70%	—	—
	—	-7.76	-5.96	—
	—	0.41	167.83	—
	—	0.24	0.30	—
	—	7.65	14.90	—
	—	104.3	112.0	—
Balance sheet
	—	106.59	78.29	—
	—	49.87	28.76	—
	—	9.51	0.24	—
	—	20.69	15.94	—
	—	3.03	1.62	—
	—	8.26	5.97	—
	—	25.44	22.70	—
	—	6.13	3.18	—
	—	19.89	12.07	—
	—	17.16	15.14	—
	—	7.06	3.41	—
	—	10.10	11.73	—
	—	72.95	50.07	—
Cash flow
	—	0.42	10.07	—
	—	-9.98	-15.62	—
	—	18.83	5.24	—
	—	8.18	16.03	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	16.93	18.38	16.91	10.43	8.22	8.93	11.87	10.30	12.52	—
	0.26	0.37	0.18	0.26	0.38	0.14	0.22	0.16	0.11	—
	17.20	18.74	17.09	10.70	8.59	9.07	12.08	10.46	12.63	—
	15.02	16.51	13.99	10.79	11.19	11.72	11.32	9.88	10.56	—
	1.58	1.49	1.38	0.94	0.62	1.12	0.81	0.77	0.95	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	4.95	4.95	4.57	4.26	4.21	4.61	3.68	3.71	3.65	—
	0.30	0.25	0.38	0.38	0.36	0.35	0.26	0.27	0.15	—
	1.43	1.36	1.35	1.45	1.50	1.53	1.23	1.25	1.28	—
	6.77	8.46	6.31	3.77	4.49	4.10	5.34	3.88	4.53	—
	2.18	2.23	3.10	-0.09	-2.59	-2.65	0.77	0.58	2.07	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	2.18	2.23	3.10	-0.09	-2.59	-2.65	0.77	0.58	2.07	—
	0.29	0.64	0.80	-0.01	-0.43	1.31	0.44	0.44	0.47	—
	1.89	1.59	2.30	-0.09	-2.16	-1.34	0.32	0.15	1.60	—
	0.95	0.80	1.45	-0.05	-1.36	-0.86	0.21	0.10	1.03	—
Key metrics
	3.91	3.84	4.83	1.74	-0.73	-0.77	2.26	2.10	3.50	—
	23.10%	20.90%	28.60%	16.70%	-8.90%	-8.60%	19.00%	20.40%	28.00%	—
	11.20%	8.70%	13.60%	-0.90%	-26.30%	-15.00%	2.70%	1.50%	12.80%	—
	—	3.00%	—	0.50%	—	-3.70%	—	—	—	—
	106.00%	105.80%	42.50%	1.30%	-34.30%	—	—	—	—	—
	187.50%	218.70%	618.70%	-160.00%	-235.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	62.65	53.93	43.61	—
	1.07	1.19	0.63	—
	63.73	55.12	44.24	—
	56.31	52.48	43.47	—
	5.39	4.43	3.65	—
	0.00	0.00	0.00	—
	18.73	17.99	15.65	—
	1.31	1.38	1.04	—
	5.59	5.65	5.29	—
	25.31	23.02	17.84	—
	7.42	2.64	0.77	—
	0.00	0.00	0.00	—
	7.42	2.64	0.77	—
	1.72	0.99	0.04	—
	5.69	1.65	0.74	—
	3.15	0.83	0.47	—
Key metrics
	14.32	9.67	7.10	—
	22.86%	17.90%	16.30%	—
	9.08%	3.10%	1.70%	—
	—	4.80%	2.90%	—
	59.33%	23.70%	—	—
	—	123.00%	—	—
	—	-8.79	-7.34	—
	—	1.55	4.00	—
	—	0.16	0.16	—
	—	2.11	8.03	—
	—	100.8	105.4	—
Balance sheet
	—	99.25	70.62	—
	—	50.57	29.91	—
	—	9.47	0.21	—
	—	18.53	14.39	—
	—	1.61	0.93	—
	—	6.26	4.38	—
	—	20.93	17.57	—
	—	5.24	2.73	—
	—	16.31	8.49	—
	—	11.58	8.24	—
	—	5.23	2.22	—
	—	6.35	6.02	—
	—	73.30	50.92	—
Cash flow
	—	2.56	2.96	—
	—	-13.92	-9.84	—
	—	20.62	6.58	—
	—	11.35	10.30	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +59.33%
Profit YoY (TTM): +287.79%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +66.05%
Profit YoY (TTM): +222.49%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 30.01%

Quarter	September 2026	June 2026
Promoter %	30.01%	30.23%

Holder	Type	Holding	Previous	Change
KRISHNA KISHORE KUCHIPUDI	Promoter	9.64%	9.71%	-0.07%
K VANAJA	Promoter	7.84%	7.90%	-0.06%
CHENNAMANENI SUSHMITHA	Public	7.47%	7.53%	-0.06%
JEEVAN KRISHNA KUCHIPUDI	Promoter Group	4.57%	4.61%	-0.04%
GOPI KRISHNA KILARU	Promoter	3.59%	3.61%	-0.02%
DHEERAJ KUMAR LOHIA	Public	2.62%	2.65%	-0.03%
SHEELA BANGAD	Public	2.49%	2.51%	-0.02%
RADHIKA RAMPA	Public	2.49%	2.51%	-0.02%
SHRADHA BANGAD	Public	1.99%	2.01%	-0.02%
RAVI THAMMAREDDY .	Promoter	1.96%	1.97%	-0.01%
PRITY AGARWAL	Public	1.72%	1.74%	-0.02%
DURISALA DESAIAH	Public	1.64%	1.66%	-0.02%
PRANALI BANGAD	Public	1.49%	1.51%	-0.02%
SUSHMA BANGAD	Public	1.49%	1.51%	-0.02%
RED SOIL PARTNERS LLP	Public	1.25%	1.26%	-0.01%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Syngene International Limited	16,841	417.20	90.49	8.40%	-5.99% TTM	-60.25% TTM	-35.44%
Indegene Limited	14,870	617.05	36.17	15.40%	+35.84% TTM	-7.78% TTM	+14.61%
Suven Life Sciences Ltd.	7,803	276.15	-22.14	-46.50%	+17.29% TTM	-91.30% TTM	+40.18%
Vimta Labs Ltd.	2,230	498.80	—	—	+4.90% TTM	+48.48% TTM	-24.58%
NOVELIX PHARMACEUTICALS LIMITED S	194	68.00	53.54	6.70%	+179.89% TTM	+535.09% TTM	+29.52%
Bilcare Ltd.	183	77.69	16.51	9.20%	+11.44% TTM	+125.02% TTM	-25.62%
TAKE LIMITED S	170	11.47	29.00	11.10%	-15.35% TTM	+124.35% TTM	-52.11%
Jeevan Scientific Technology Limited	164	81.70	32.02	4.80%	+66.05% TTM	+222.49% TTM	+30.72%
GlobalSpace Technologies Limited	99	28.84	29.21	5.00%	+37.21% TTM	+398.53% TTM	+63.12%
Adeshwar Meditex Limited S	27	18.80	21.36	6.00%	—	—	+1.62%
Vanta Bioscience Limited	14	20.39	—	1.50%	—	—	-5.86%

Filings & corporate actions

Recent announcements

Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve Intimation of ....4 Nov 2026 · Board Meeting / Board Meeting
Compliance as per Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 202614 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Announcement under Regulation 30 of SEBI (LODR) Regulations, 20151 Oct 2026 · Company Update / General
Closure of trading window under SEBI (Prohibition of Insider Trading) Regulations, 2015.29 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Disclosure under Regulation 44(3) (Listing Obligations and Disclosure Requirements) Regulations, 2015.25 Sep 2026 · AGM/EGM / AGM
Outcome of 28th Annual General Meeting held on 25-09-202625 Sep 2026 · AGM/EGM / AGM
Newspaper Advertisement -Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.4 Sep 2026 · Company Update / Newspaper Publication
Intimation of Book Closure and Cut- off date for the 28th Annual General Meeting of the Company3 Sep 2026 · AGM/EGM / AGM
28th Annual report3 Sep 2026 · Others / Reg. 34 (1) Annual Report
28th Annual General meeting of the Company is scheduled to be held on 25.09.2026 at 10:00 a.m.3 Sep 2026 · AGM/EGM / AGM
Statement on Deviation or Variation of funds under Regulation 32 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.13 Aug 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Announcement under Regulation 30 (LODR)- change in management13 Aug 2026 · Company Update / Change in Management
Unaudited financial results (standalone and consolidated) for the quarter ended 30.06.2026.13 Aug 2026 · Result / Financial Results
Outcome of the Board Meeting held on 13.08.202613 Aug 2026 · Board Meeting / Outcome of Board Meeting
Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Intimation of ....10 Aug 2026 · Board Meeting / Board Meeting
Intimation of Approval for addition of Beds to the Existing Approved Bioavailability/ Bioequivalence Center of Jeevan Scientific Technology Limited''s Bioavailability/ Bioequivalence Study ....1 Aug 2026 · Company Update / General
Information about the Successful Completion of USFDA Inspection at JSTL under Regulation 30 of SEBI (LODR) Regulations, 2015.24 Jul 2026 · Company Update / General
Compliance as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30.06.2026.16 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Notification of Inspection for additional beds to the Existing Approved Bioavailability/ Bioequivalence center of Jeevan Scientific Technology.25 Jun 2026 · Company Update / General
Closure of Trading Window25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Annual Secretarial Compliance Report for the Financial year ended 31st March,2026 as per Regulation 24 A of SEBI (Listing and Disclosure Requirements) Regulations, 2015(''Listing Regulations)29 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Statement of Deviation or Variation of funds under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015.29 May 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Appointment of M/s. KP & Associates, Chartered Accountants as Internal Auditors of the Company for the FY 2026-2729 May 2026 · Company Update / Change in Management
Audited financial results for the quarter and year ended 31.03.202629 May 2026 · Result / Financial Results
Outcome of Board Meeting held on 29.05.202629 May 2026 · Board Meeting / Outcome of Board Meeting
Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Intimation of ....21 May 2026 · Board Meeting / Board Meeting
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''> <tr> <td>Sr. No.</td> <td>Particulars</td> ....30 Apr 2026 · Others / Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....30 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''> <tr> <td>Sr. No.</td> <td>Particulars</td> ....30 Apr 2026 · Others / Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....30 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Compliance as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended March 31,2026.14 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nageswar Rao Yarlagadda30 Mar 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nageswar Rao Yarlagadda30 Mar 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015.25 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Unaudited Financial Results for the quarter ended 31-12-2025.11 Feb 2026 · Result / Financial Results
Outcome of Board Meeting held on 11-02-202611 Feb 2026 · Others / Outcome without intimation
Disclosure under Regulation 30 of (LODR) Regulations, 201522 Jan 2026 · Company Update / General
Compliances as per Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025.13 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Padmaja Private Trust7 Jan 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vanaja Kuchipudi, Jeevan Kuchipudi and Krishna Kuchipudi7 Jan 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Board meetings

13 Aug 2026 Board Meeting - Financial Results